STAT+: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment
Stat News • 2/4/2026
Summary
Trump administration officials blocked the FDA's effort to fast-track the review of a psychedelic treatment for severe depression, according to STAT.
Advertisement
Lindy Score Breakdown (V4.2)
57d
Age
1
Sources
from cluster
1390
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1390/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1390/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 57 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 1 day ago
STAT+: Can a psychedelic ‘coach’ make ketamine therapy even more effective?
Stat News • 2 days ago
STAT+: Psychedelic biotechs face scrutiny over YouTube promos
Stat News • 2 days ago
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • Today
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • Today
STAT+: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback
Stat News • 2 days ago
STAT+: Whoop, maker of health and fitness tracking wristbands, valued at $10 billion after latest fundraising
Stat News • 2 days ago
STAT+: Baby KJ scientists hit speed bump in quest to scale custom gene editor
Stat News • 2 days ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • Today
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Stat News • Today